125 related articles for article (PubMed ID: 31010523)
1. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
Huang C; Zhou M; Zheng X
J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
[TBL] [Abstract][Full Text] [Related]
2. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
Huang C; Zhao J; Zhu Y
J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Huang C; Zhang W; Zhu Y
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
[TBL] [Abstract][Full Text] [Related]
4. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
[TBL] [Abstract][Full Text] [Related]
5. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
6. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
7. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
8. Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells.
Gadang V; Konaniah E; Hui DY; Jaeschke A
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1429-36. PubMed ID: 24790140
[TBL] [Abstract][Full Text] [Related]
9. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
[TBL] [Abstract][Full Text] [Related]
10. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation.
Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963
[TBL] [Abstract][Full Text] [Related]
11. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.
Huang C; Mei H; Zhou M; Zheng X
Mol Med Rep; 2017 Jan; 15(1):21-28. PubMed ID: 27922693
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
14. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
15. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
[TBL] [Abstract][Full Text] [Related]
16. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
17. Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.
Wu JH; Fanaroff AC; Sharma KC; Smith LS; Brian L; Eipper BA; Mains RE; Freedman NJ; Zhang L
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):702-8. PubMed ID: 23288169
[TBL] [Abstract][Full Text] [Related]
18. Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1.
Hyvelin JM; Maurel B; Uzbekov R; Motterlini R; Lermusiaux P
J Vasc Surg; 2010 Feb; 51(2):417-28. PubMed ID: 20022212
[TBL] [Abstract][Full Text] [Related]
19. Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries.
Pendyala L; Yin X; Li J; Shinke T; Xu Y; Chen JP; King SB; Colley K; Goodchild T; Chronos N; Hou D
EuroIntervention; 2010 May; 6(1):126-33. PubMed ID: 20542808
[TBL] [Abstract][Full Text] [Related]
20. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
J Vasc Interv Radiol; 2018 Jul; 29(7):1041-1049.e3. PubMed ID: 29754850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
